Survey of the Anxiety Associated With the COVID-19 Pandemic

NCT ID: NCT04331106

Last Updated: 2021-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

7500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-03-27

Study Completion Date

2022-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to systematically examine various aspects of the anxiety associated with the COVID-19 pandemic in Germany. The data collection is carried out online with longitudinal repeated measurements.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The COVID-19 pandemic is currently one of the greatest challenges for numerous countries - also for Germany. In addition to its somatic and economic consequences, the psychological dimension of the Coronavirus pandemic is discussed increasingly and is visible in public life - e.g. in the "pandemic-caused experience of threat", "loss of control" and "panic" of multiple people. The study examines the phenomenon of this "corona-related anxiety" in terms of epidemiological, clinical and psychosocial characteristics. It is investigated how "corona anxiety" affects people who already have an anxiety disorder or other mental illnesses as well as formerly mentally healthy people. It is also examined how media reporting and personal consequences of COVID-19 are connected with corona-related anxiety and if there is a need for therapeutic support regarding corona-related anxiety.

To answer these questions a longitudinal online survey targeting the general population in Germany is carried out. The survey takes place all three weeks as long as the pandemic lasts and ends with one follow-up one year later.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Related to the COVID-19 Pandemic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Population in Germany

Reasonably large and representative sample of the general population in Germany

Online Questionnaire

Intervention Type DIAGNOSTIC_TEST

Online Questionnaire via SoSci Survey

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Online Questionnaire

Online Questionnaire via SoSci Survey

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* informed consent was given
* age ≥ 18
* able to complete the questionnaire in German
* country of residence: Germany
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Charite University, Berlin, Germany

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Antonia Bendau

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andreas Ströhle, Prof.Dr.

Role: STUDY_DIRECTOR

Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy

Antonia Bendau, M.Sc.Psych.

Role: PRINCIPAL_INVESTIGATOR

Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy

Berlin, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Antonia Bendau, M.Sc.Psych.

Role: CONTACT

+4930450517274

Andreas Ströhle, Prof.Dr.

Role: CONTACT

+4930450517217

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Role: primary

+49 30 450 517 285

References

Explore related publications, articles, or registry entries linked to this study.

Bendau A, Petzold MB, Strohle A, Plag J. Viral Transmission? A Longitudinal Study of Media Use and Its Relation to Mental Strain During the First 2 Years of the COVID-19 Pandemic. Int J Behav Med. 2025 Apr;32(2):214-226. doi: 10.1007/s12529-024-10293-3. Epub 2024 May 20.

Reference Type DERIVED
PMID: 38769221 (View on PubMed)

Bendau A, Petzold MB, Plag J, Asselmann E, Strohle A. Illness anxiety predicts higher mental strain and vaccine willingness-A nine-wave longitudinal study during the first 1.5 years of the COVID-19 pandemic in Germany. Stress Health. 2023 Dec;39(5):1137-1147. doi: 10.1002/smi.3255. Epub 2023 May 9.

Reference Type DERIVED
PMID: 37158010 (View on PubMed)

Olsson A, Olsson M, Fedorowski A, Hagell P, Wictorin K. The Orthostatic Hypotension Questionnaire in Swedish tested in patients with parkinsonism. Brain Behav. 2020 Sep;10(9):e01746. doi: 10.1002/brb3.1746. Epub 2020 Jul 7.

Reference Type DERIVED
PMID: 32633094 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EA1/071/20

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mechanisms of Panic Disorders Treatment
NCT01323556 UNKNOWN PHASE2/PHASE3